{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:01:38Z","timestamp":1792116098643,"version":"4.4.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.phrs.2023.106972","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:42:08Z","timestamp":1698446528000},"page":"106972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease"],"prefix":"10.1016","volume":"197","author":[{"given":"Nehal","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ditmarsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Dicklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOL.0000000000000854","article-title":"Can we revive CETP-inhibitors for the prevention of cardiovascular disease?","volume":"33","author":"Nicholls","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"issue":"13","key":"10.1016\/j.phrs.2023.106972_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"16","key":"10.1016\/j.phrs.2023.106972_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169417","article-title":"Cholesteryl Ester transfer protein inhibition reduces major adverse cardiovascular events by lowering apolipoprotein B levels","volume":"23","author":"Nelson","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.phrs.2023.106972_bib4","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1093\/cvr\/cvab350","article-title":"Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?","volume":"118","author":"Nurmohamed","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"21","key":"10.1016\/j.phrs.2023.106972_bib5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"I. Investigators, effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"New Engl. J. Med."},{"issue":"22","key":"10.1016\/j.phrs.2023.106972_bib6","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"New Engl. J. Med."},{"issue":"20","key":"10.1016\/j.phrs.2023.106972_bib7","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"A. investigators, evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"14","key":"10.1016\/j.phrs.2023.106972_bib8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/eurheartj\/ehab863","article-title":"Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease","volume":"43","author":"Group","year":"2022","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.phrs.2023.106972_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/s41591-022-01936-7","article-title":"Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial","volume":"28","author":"Nicholls","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106972_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2023.05.098","article-title":"Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: a randomized phase 2 trial","author":"Ballantyne","year":"2023","journal-title":"J. Clin. Lipidol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-022-01012-y","article-title":"The role of high-density lipoprotein cholesterol in 2022","volume":"24","author":"Sirtori","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOL.0000000000000604","article-title":"HDL from an Alzheimer's disease perspective","volume":"30","author":"Button","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.phrs.2023.106972_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9121224","article-title":"HDL proteome and Alzheimer's disease: evidence of a link","volume":"9","author":"Marsillach","year":"2020","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00415-005-0945-2","article-title":"Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele","volume":"253","author":"Rodr\u00edguez","year":"2006","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11682-011-9137-0","article-title":"CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner","volume":"6","author":"Murphy","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.phrs.2023.106972_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2016.02.006","article-title":"Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein \u03b54 on memory decline in older adults","volume":"41","author":"Sundermann","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.diabet.2018.02.005","article-title":"Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk","volume":"44","author":"Masson","year":"2018","journal-title":"Diabetes Metab."},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tem.2020.01.003","article-title":"Role for CETP as Immunological Gatekeeper: raising HDL to Cure Sepsis?","volume":"31","author":"Blauw","year":"2020","journal-title":"Trends Endocrinol. Metab.: TEM"},{"issue":"21","key":"10.1016\/j.phrs.2023.106972_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112965","article-title":"Impact of high-density lipoproteins on sepsis","volume":"23","author":"De Geest","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003246-199604000-00006","article-title":"Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia","volume":"24","author":"Gordon","year":"1996","journal-title":"Crit. care Med."},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit. care Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-02860-3","article-title":"High-density lipoproteins during sepsis: from bench to bedside","volume":"24","author":"Tanaka","year":"2020","journal-title":"Crit. care"},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","article-title":"Cholesteryl Ester transfer protein influences high-density lipoprotein levels and survival in sepsis","volume":"199","author":"Trinder","year":"2019","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.120.048568","article-title":"Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis","volume":"143","author":"Trinder","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2021.3728","article-title":"Long-term benefits and harms associated with genetic cholesteryl ester transfer protein deficiency in the general population","volume":"7","author":"Nordestgaard","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25703-3","article-title":"Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamacardio.2022.1276","article-title":"Macular degeneration and CETP inhibition","volume":"7","author":"Tall","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jacc.2022.06.007","article-title":"Interpreting the clinical implications of drug-target mendelian randomization studies","volume":"80","author":"Ference","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.phrs.2023.106972_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169356","article-title":"HDL-like-mediated cell cholesterol trafficking in the central nervous system and Alzheimer's disease pathogenesis","volume":"23","author":"Borr\u00e0s","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106972_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092161","article-title":"Targeting apolipoprotein E for Alzheimer's disease: an industry perspective","volume":"20","author":"Suidan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106972_bib33","doi-asserted-by":"crossref","unstructured":"F. Yin, Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise, The FEBS journal (2022).","DOI":"10.1111\/febs.16344"},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer's Disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2023.106972_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.700847","article-title":"Understanding the exchange of systemic HDL particles into the brain and vascular cells has diagnostic and therapeutic implications for neurodegenerative diseases","volume":"12","author":"Van Valkenburgh","year":"2021","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106972_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102439","article-title":"The positive side of the Alzheimer's disease amyloid cross-interactions: the case of the A\u03b2 1-42 peptide with Tau, TTR, CysC, and ApoA1","volume":"25","author":"Ciccone","year":"2020","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100260","article-title":"The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain","volume":"63","author":"Oestereich","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2023.106972_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/alz.051134","article-title":"Cholesterol metabolism in Alzheimer\u2019s disease","volume":"17","author":"Phenix","year":"2021","journal-title":"Alzheimer\u2019s Dement"},{"issue":"8","key":"10.1016\/j.phrs.2023.106972_bib40","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE cascade hypothesis in the pathogenesis of Alzheimer's disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.phrs.2023.106972_bib41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071495","article-title":"High-density lipoprotein changes in Alzheimer's disease are APOE genotype-specific","volume":"10","author":"Hong","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2023.106972_bib43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fnins.2019.00419","article-title":"The extent of human apolipoprotein A-I lipidation strongly affects the \u03b2-amyloid efflux across the blood-brain barrier in vitro","volume":"13","author":"Dal Magro","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2023.106972_bib44","doi-asserted-by":"crossref","unstructured":"A.E. Martinez, G. Weissberger,\u00a0Z. Kuklenyik,\u00a0X. He,\u00a0C. Meuret,\u00a0T. Parekh,\u00a0J.C. Rees,\u00a0B.A. Parks,\u00a0M.S. Gardner,\u00a0S.M. King,\u00a0T.S. Collier,\u00a0M.G. Harrington,\u00a0M.D. Sweeney,\u00a0X. Wang,\u00a0B.V. Zlokovic,\u00a0E. Joe,\u00a0D.A. Nation,\u00a0L.S. Schneider,\u00a0H.C. Chui,\u00a0J.R. Barr,\u00a0S.D. Han,\u00a0R.M. Krauss,\u00a0H.N. Yassine,\u00a0The small HDL particle hypothesis of Alzheimer's disease, Alzheimer's & dementia: the journal of the Alzheimer's Association (2022).","DOI":"10.1002\/alz.12649"},{"key":"10.1016\/j.phrs.2023.106972_bib45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neurobiolaging.2017.08.028","article-title":"Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease","volume":"60","author":"Fern\u00e1ndez-de Retana","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.phrs.2023.106972_bib46","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4103\/1673-5374.310669","article-title":"Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's disease","volume":"16","author":"Endres","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"12","key":"10.1016\/j.phrs.2023.106972_bib47","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","article-title":"Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease","volume":"54","author":"Holstege","year":"2022","journal-title":"Nat. Genet."},{"issue":"9992","key":"10.1016\/j.phrs.2023.106972_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(15)60158-1","article-title":"Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"386","author":"Hovingh","year":"2015","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.phrs.2023.106972_bib49","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2015.09.013","article-title":"Cholesterol Efflux capacity and pre-beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib","volume":"66","author":"Nicholls","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jacl.2016.06.006","article-title":"Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses","volume":"10","author":"van Capelleveen","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phrs.2023.106972_bib51","article-title":"inhibitor evacetrapib enters mouse brain tissue","author":"Phenix","year":"2023","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ehjcvp\/pvac025","article-title":"The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis","volume":"8","author":"Dangas","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.phrs.2023.106972_bib53","article-title":"Type 2 diabetes and HDL dysfunction: a key contributor to Glycemic Control","author":"Rotllan","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-021-01499-5","article-title":"Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus among Chinese: the Beijing longitudinal study of aging","volume":"20","author":"Cao","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/epirev\/mxq019","article-title":"Risk assessment tools for identifying individuals at risk of developing type 2 diabetes","volume":"33","author":"Buijsse","year":"2011","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.phrs.2023.106972_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fphar.2015.00258","article-title":"HDL and glucose metabolism: current evidence and therapeutic potential","volume":"6","author":"Siebel","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diabetes.53.3.513","article-title":"Transcriptional control of apolipoprotein A-I gene expression in diabetes","volume":"53","author":"Mooradian","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib58","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/jc.2017-01551","article-title":"Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes","volume":"103","author":"Kashyap","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.mol.0000226115.97436.c0","article-title":"Diabetic dyslipidaemia","volume":"17","author":"Adiels","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOL.0b013e3280e12685","article-title":"Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins","volume":"18","author":"Dallinga-Thie","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrendo.2011.235","article-title":"The emerging role of HDL in glucose metabolism","volume":"8","author":"Drew","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"22","key":"10.1016\/j.phrs.2023.106972_bib62","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"New Engl. J. Med."},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib63","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/db14-1710","article-title":"Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes","volume":"64","author":"Fall","year":"2015","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib64","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106972_bib65","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/en.2009-0252","article-title":"Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells","volume":"150","author":"R\u00fctti","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib66","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1194\/jlr.RA119000509","article-title":"HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic \u03b2-cells in vitro by activation of Smoothened","volume":"61","author":"Yalcinkaya","year":"2020","journal-title":"J. Lipid Res"},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MOL.0b013e328339387b","article-title":"HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus","volume":"21","author":"Kruit","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106972_bib68","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106972_bib69","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1172\/JCI41280","article-title":"An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells","volume":"120","author":"Sturek","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2023.106972_bib70","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.RA120000920","article-title":"Giudice structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux","volume":"62","author":"Nilsson","year":"2021","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2337\/dc09-1562","article-title":"Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction","volume":"33","author":"Vergeer","year":"2010","journal-title":"Diabetes care"},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/db14-0436","article-title":"Loss-of-function mutations in ABCA1 and enhanced \u03b2-cell secretory capacity in young adults","volume":"64","author":"Rickels","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2023.106972_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12986-016-0082-1","article-title":"The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice","volume":"13","author":"Guo","year":"2016","journal-title":"Nutr. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056601","article-title":"Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein","volume":"8","author":"Carey","year":"2013","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.phrs.2023.106972_bib75","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib76","article-title":"Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle","volume":"9","author":"Tang","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.113.300689","article-title":"Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion","volume":"113","author":"Siebel","year":"2013","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.phrs.2023.106972_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018136","article-title":"Effect of anacetrapib on cholesterol efflux capacity: a substudy of the DEFINE Trial","volume":"9","author":"Metzinger","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.phrs.2023.106972_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2014.01.028","article-title":"Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters","volume":"233","author":"Briand","year":"2014","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib80","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"New Engl. J. Med."},{"issue":"10219","key":"10.1016\/j.phrs.2023.106972_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.phrs.2023.106972_bib82","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib83","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcrc.2015.01.001","article-title":"Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission","volume":"30","author":"Chien","year":"2015","journal-title":"J. Crit. care"},{"key":"10.1016\/j.phrs.2023.106972_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcrc.2016.11.041","article-title":"Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis","volume":"38","author":"Cirstea","year":"2017","journal-title":"J. Crit. care"},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib85","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.12601","article-title":"Two-year follow-up of patients with septic shock presenting with low HDL: the effect upon acute kidney injury, death and estimated glomerular filtration rate","volume":"281","author":"Roveran Genga","year":"2017","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib86","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-2275(20)37259-X","article-title":"Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I","volume":"38","author":"Massamiri","year":"1997","journal-title":"J. Lipid Res."},{"issue":"23","key":"10.1016\/j.phrs.2023.106972_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235939","article-title":"Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond","volume":"20","author":"Fuior","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.phrs.2023.106972_bib88","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib89","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/hep.27985","article-title":"Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib90","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008105","article-title":"Lipopolysaccharide lowers cholesteryl ester transfer protein by activating F4\/80(+)Clec4f(+)Vsig4(+)Ly6C(-) kupffer cell subsets","volume":"7","author":"van der Tuin","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib91","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI117832","article-title":"Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice","volume":"95","author":"Masucci-Magoulas","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.phrs.2023.106972_bib92","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1172\/JCI118707","article-title":"Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters","volume":"97","author":"Hardard\u00f3ttir","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2023.106972_bib93","article-title":"Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals","author":"Harslof","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib94","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41431-018-0301-5","article-title":"Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile","volume":"27","author":"Blauw","year":"2019","journal-title":"Eur. J. Hum. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib95","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/ATVBAHA.106.136325","article-title":"High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans","volume":"27","author":"Birjmohun","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","article-title":"High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-\u03baB\/STAT1-IRF1 signaling","volume":"25","author":"van der Vorst","year":"2017","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094547","article-title":"HDL cholesterol and non-cardiovascular disease: a narrative review","volume":"22","author":"Kjeldsen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2023.106972_bib98","first-page":"3216","article-title":"CETP deficiency","volume":"52","author":"Inazu","year":"1994","journal-title":"Nihon Rinsho"},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib99","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI117537","article-title":"Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol","volume":"94","author":"Inazu","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.phrs.2023.106972_bib100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMcp2102061","article-title":"Age-related macular degeneration","volume":"385","author":"Apte","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2023.106972_bib101","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1194\/jlr.R010538","article-title":"The ins and outs of cholesterol in the vertebrate retina","volume":"51","author":"Fliesler","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2023.106972_bib102","first-page":"1306","article-title":"Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process","volume":"12","author":"Tserentsoodol","year":"2006","journal-title":"Mol. Vis."},{"issue":"10","key":"10.1016\/j.phrs.2023.106972_bib103","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2023.106972_bib104","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/bbrc.2002.6756","article-title":"Human retinal pigment epithelial cells express scavenger receptors BI and BII","volume":"292","author":"Duncan","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.18240\/ijo.2023.01.05","article-title":"Apolipoprotein A1 suppresses the hypoxia-induced angiogenesis of human retinal endothelial cells by targeting PlGF","volume":"16","author":"Hu","year":"2023","journal-title":"Int J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib106","article-title":"Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration","volume":"100 Suppl 1","author":"Koo","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.phrs.2023.106972_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090390","article-title":"Zeaxanthin: metabolism, properties, and antioxidant protection of eyes, heart, liver, and skin","volume":"8","author":"Murillo","year":"2019","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.phrs.2023.106972_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10081255","article-title":"A systematic review of carotenoids in the management of age-related macular degeneration","volume":"10","author":"Lem","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2023.106972_bib109","article-title":"Macular and plasma xanthophylls are higher in age-related macular degeneration than in normal aging","volume":"3","author":"McGwin","year":"2023","journal-title":"Opthalmol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2023.106972_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2020.08.018","article-title":"Dietary nutrient intake and progression to late age-related macular degeneration in the age-related eye disease studies 1 and 2","volume":"128","author":"Agron","year":"2021","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.phrs.2023.106972_bib111","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1194\/jlr.M070193","article-title":"Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins","volume":"57","author":"Thomas","year":"2016","journal-title":"J. Lipid Res."},{"issue":"44","key":"10.1016\/j.phrs.2023.106972_bib112","doi-asserted-by":"crossref","first-page":"37321","DOI":"10.1074\/jbc.M112.380063","article-title":"Crystal structures of cholesteryl ester transfer protein in complex with inhibitors","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106972_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010105","article-title":"HDL functions-current status and future perspectives","volume":"13","author":"Endo","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.phrs.2023.106972_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.861","article-title":"SARS-CoV-2 induced HDL dysfunction may affect the host's response to and recovery from COVID-19","volume":"11","author":"Al-Kuraishy","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"25","key":"10.1016\/j.phrs.2023.106972_bib115","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by dalcetrapib","volume":"6","author":"Niesor","year":"2021","journal-title":"ACS Omega"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:50:37Z","timestamp":1760914237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":115,"alternative-id":["S1043661823003286"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106972","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106972"}}